BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei Y, Fu Y, Liu S, Xia G, Pan S. Effect of lentiviruses carrying enhanced green fluorescent protein injected into the scala media through a cochleostomy in rats. Am J Otolaryngol 2013;34:301-7. [PMID: 23465349 DOI: 10.1016/j.amjoto.2012.12.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Ahmed H, Shubina-Oleinik O, Holt JR. Emerging Gene Therapies for Genetic Hearing Loss. J Assoc Res Otolaryngol 2017;18:649-70. [PMID: 28815315 DOI: 10.1007/s10162-017-0634-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 11.5] [Reference Citation Analysis]
2 Delmaghani S, El-Amraoui A. Inner Ear Gene Therapies Take Off: Current Promises and Future Challenges. J Clin Med 2020;9:E2309. [PMID: 32708116 DOI: 10.3390/jcm9072309] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
3 Ayoob AM, Borenstein JT. The role of intracochlear drug delivery devices in the management of inner ear disease. Expert Opin Drug Deliv 2015;12:465-79. [PMID: 25347140 DOI: 10.1517/17425247.2015.974548] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
4 Silva SA, Maass JC. p27Kip1 down-regulation as achieved by two clinically feasible means did not induce proliferation of supporting cells in the rat neonatal cochlea in vivo. Hear Res 2019;373:10-22. [PMID: 30578960 DOI: 10.1016/j.heares.2018.12.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Lee S, Dondzillo A, Gubbels SP, Raphael Y. Practical aspects of inner ear gene delivery for research and clinical applications. Hear Res 2020;394:107934. [PMID: 32204962 DOI: 10.1016/j.heares.2020.107934] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ding N, Lee S, Lieber-Kotz M, Yang J, Gao X. Advances in genome editing for genetic hearing loss. Adv Drug Deliv Rev 2021;168:118-33. [PMID: 32387678 DOI: 10.1016/j.addr.2020.05.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Chen X, Zhao X, Hu Y, Lan F, Sun H, Fan G, Sun Y, Wu J, Kong W, Kong W. The spread of adenoviral vectors to central nervous system through pathway of cochlea in mimetic aging and young rats. Gene Ther 2015;22:866-75. [PMID: 26125607 DOI: 10.1038/gt.2015.63] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
8 Géléoc GGS, El-Amraoui A. Disease mechanisms and gene therapy for Usher syndrome. Hear Res 2020;394:107932. [PMID: 32199721 DOI: 10.1016/j.heares.2020.107932] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
9 Gordon SA, Gurgel RK. Past and Future Biologics for Otologic Disorders. Otolaryngol Clin North Am 2021;54:779-87. [PMID: 34119333 DOI: 10.1016/j.otc.2021.05.003] [Reference Citation Analysis]